Lijuan Jiang

590 citations
38 papers · 373 indexed · h-index 12
Topics
Bladder and Urothelial Cancer Treatments (11 papers)RNA modifications and cancer (7 papers)Renal cell carcinoma treatment (6 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaNano Letters

In The Last Decade

Lijuan Jiang

36 papers receiving 368 citations

Peers

Lijuan Jiang
Comparison fields: 5 of 69
  • Molecular Biology 200
  • Pulmonary and Respiratory Medicine 105
  • Surgery 98
  • Cancer Research 78
  • Global and Planetary Change 54
Replace Daniele Spada with:
Daniele Spada Italy
Yun Qiao China
Concetta Di Mauro Italy
Hye-Lim Lee South Korea
Zhijie Yin China
John D. Karalis United States
Linna Ge United States
Hongke Cai China
Ting Zhan China
Lijuan Jiang relative to Daniele Spada Italy Daniele Spada's profile →
Citations per field
00.5×5.2×
Daniele Spada · 1×
Citations per year

Countries citing papers authored by Lijuan Jiang

Since Specialization
Citations

This map shows the geographic impact of Lijuan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijuan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijuan Jiang more than expected).

Fields of papers citing papers by Lijuan Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijuan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijuan Jiang. The network helps show where Lijuan Jiang may publish in the future.

Co-authorship network of co-authors of Lijuan Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Lijuan Jiang. A scholar is included among the top collaborators of Lijuan Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijuan Jiang. Lijuan Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 1
5 0
6 14
7 3
8 11
9 5
10 5
11 33
12 8
13 13
14 16
15 15
16 1
17 32
18 16
19 18
20 19

About Lijuan Jiang

Lijuan Jiang is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 373 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (11 papers), RNA modifications and cancer (7 papers) and Renal cell carcinoma treatment (6 papers). The work is most often cited by research in Cancer Research (78 citations), Pulmonary and Respiratory Medicine (105 citations) and Molecular Biology (200 citations). Lijuan Jiang has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Fangjian Zhou, Zhiling Zhang, Hailong Wang, Yangbo Chen, Yonghong Li, Chunping Yu, Zhuowei Liu, Dan Xie, Minhua Deng and Wensu Wei. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nano Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026